Eastern Caribbean Cruise Pharmacy CE Seminar
07/25/2027 - 08/01/2027
8:00 am - 1:00 pm
Where: Norwegian Cruise Line departing Orlando, FL
Topics include: mood disorders, sleep disorders
CRUISE INFO:
aboard Norwegian Cruise Line’s Norwegian Aqua
Balcony cabins available at group rate of $1353 per person plus tax and fees. Based on double occupancy.
If you make your reservation on your own, please let us know. You will still need to register for the lectures at the bottom of this page. Seating is limited.
July 25, 2027—depart from Orlando, FL
July 26th—lecture day 8am to 1pm
July 27th—Puerto Plata, Dominican Republic
July 28th—St. Thomas, US Virgin Island
July 29th—Tortola, British Virgin Island
July 30th—lecture day 8am to 1pm
July 31st—Great Stirrup Cay, Bahamas
August 1st–return to Orlando, FL
Joshua Caballero, PharmD, BCPP, FCCP
University of Georgia, College of Pharmacy
Dr. Joshua Caballero completed a BA in Psychology from the University of Florida and received his PharmD from the University of Tennessee Health Science Center. Afterwards, he completed a psychiatric residency at the University of Texas Health Science Center at San Antonio and a pharmacotherapy fellowship at The Ohio State University. Dr. Caballero is board certified in psychiatric pharmacy and has worked extensively with underserved populations including establishing pharmacy outpatient clinical services. Dr. Caballero’s research interests include the effects of psychotropic agents in various populations and their impact on cognition, health literacy in HIV, and pharmacy education. He has presented many times at national conferences, secured extramural funding, and published in academic peer-reviewed journals. He has been the recipient of several teaching and advising awards at the University and national level.
Monday July 26, 2027
EMERGING PSYCHEDELIC THERAPIES FOR MOOD DISORDERS: PROMISE, EVIDENCE, AND LIMITATIONS
ACPE# TBD
Objectives:
- Describe the current evidence regarding the use of psychedelic-assisted therapies in the treatment of major depressive disorder.
- Discuss adjunctive treatments and supportive interventions used alongside psychedelic-assisted therapy for patients with major depressive disorder.
- Summarize the emerging evidence for psychedelic-assisted therapies in the management of anxiety and related disorders (e.g., PTSD).
- Explain supportive and adjunctive interventions used in conjunction with psychedelic-assisted therapy.
- Discuss future research directions and the evolving legal and regulatory landscape surrounding the clinical use of psychedelic therapies.
—————————————————————————————————————————————————————————————————-
Friday July 30, 2027
MANAGING SLEEP DISORDERS: PHARMACOLOGIC THERAPIES & EMERGING ROLE OF DIGITAL THERAPEUTICS
ACPE# TBD
Objectives:
- Describe the basic principles of circadian rhythms and normal sleep architecture relevant to sleep disorders.
- Identify common causes and types of sleep disorders encountered in clinical practice.
- Compare non-pharmacologic and pharmacologic treatment options used in the management of sleep disorders.
- Recognize clinically significant adverse effects, drug interactions, and safety considerations associated with commonly used sleep medications.
- Discuss digital therapeutics in sleep disorders.